-
1
-
-
0035826771
-
Practice parameter: Management of dementia (an evidence-based review). Report of the quality standards subcommittee of the american academy of neurology
-
Doody RS, Stevens JC, Beck C et al. Practice parameter: management of dementia (an evidence-based review). Report of the quality standards subcommittee of the american academy of neurology. Neurology 2001; 56: 1154-66.
-
(2001)
Neurology
, vol.56
, pp. 1154-1166
-
-
Doody, R.S.1
Stevens, J.C.2
Beck, C.3
-
2
-
-
0034877979
-
Pharmacotherapy of Alzheimer's disease: Is there a need to redefine treatment success
-
Winblad B, Brodaty H, Gauthier S et al. Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success. Int J Geriatr Psychiatry 2001; 16: 653-6.
-
(2001)
Int. J. Geriatr. Psychiatry
, vol.16
, pp. 653-656
-
-
Winblad, B.1
Brodaty, H.2
Gauthier, S.3
-
3
-
-
0016823810
-
Mini-mental state: A practical method for grading the cognitive state of patients for the clinician
-
Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
-
(1975)
J. Psychiatr. Res.
, vol.12
, pp. 189-198
-
-
Folstein, M.F.1
Folstein, S.E.2
McHugh, P.R.3
-
4
-
-
0038647765
-
Combination therapy of donepezil and vitamin E in Alzheimer disease
-
Klatte ET, Scharre DW, Nagaraja HN, Davis RA, Beversdorf DQ. Combination therapy of donepezil and vitamin E in Alzheimer disease. Alzheimer Dis Assoc Disord 2003; 17: 113-6.
-
(2003)
Alzheimer Dis. Assoc. Disord.
, vol.17
, pp. 113-116
-
-
Klatte, E.T.1
Scharre, D.W.2
Nagaraja, H.N.3
Davis, R.A.4
Beversdorf, D.Q.5
-
5
-
-
3042817491
-
Rivastigmine in Alzheimer's disease: Efficacy over two years
-
Grossberg G, Irwin P, Satlin A, Mesenbrink P, Spiegel R. Rivastigmine in Alzheimer's disease: efficacy over two years. Am J Geriatr Psychiatry 2004; 12: 420-31.
-
(2004)
Am. J. Geriatr. Psychiatry
, vol.12
, pp. 420-431
-
-
Grossberg, G.1
Irwin, P.2
Satlin, A.3
Mesenbrink, P.4
Spiegel, R.5
-
6
-
-
16344394107
-
Four years treatment with galantamine: Long-term cognition effects in Alzheimer's disease
-
(Abstract P2133)
-
Truyen L, Hammond G, Schwalen S. Four years treatment with galantamine: long-term cognition effects in Alzheimer's disease. Eur J Neurol 2003; 10 (Suppl. 11): 161 (Abstract P2133).
-
(2003)
Eur. J. Neurol.
, vol.10
, Issue.SUPPL. 11
, pp. 161
-
-
Truyen, L.1
Hammond, G.2
Schwalen, S.3
-
7
-
-
0031902795
-
A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease
-
Corey-Bloom J, Anand R, Veach J. A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease. Int J Geriatr Psychopharmacol 1998; 1: 55-65.
-
(1998)
Int. J. Geriatr. Psychopharmacol.
, vol.1
, pp. 55-65
-
-
Corey-Bloom, J.1
Anand, R.2
Veach, J.3
-
8
-
-
0033528436
-
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International randomised controlled trial
-
Rösler M, Anand R, Cicin-Sain A et al. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ 1999; 318: 633-40.
-
(1999)
BMJ
, vol.318
, pp. 633-640
-
-
Rösler, M.1
Anand, R.2
Cicin-Sain, A.3
-
9
-
-
0034046848
-
Dose-response effect of rivastigmine in the treatment of Alzheimer's disease
-
Anand R, Messina J, Hartman R. Dose-response effect of rivastigmine in the treatment of Alzheimer's disease. Int J Geriat Psychopharm 2000; 2: 68-72.
-
(2000)
Int. J. Geriat. Psychopharm.
, vol.2
, pp. 68-72
-
-
Anand, R.1
Messina, J.2
Hartman, R.3
-
11
-
-
18544403400
-
Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: A rapid and systematic review
-
Bryant J, Clegg A, Nicholson T et al. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. Health Technol Assess 2001; 5: 1-137.
-
(2001)
Health Technol. Assess.
, vol.5
, pp. 1-137
-
-
Bryant, J.1
Clegg, A.2
Nicholson, T.3
-
12
-
-
0012644308
-
-
Odessa, FL, USA: PAR Psychological Assessment Resources, Inc
-
Folstein MF, Folstein SE, McHugh PR, Fanjang G. MMSE - Mini-Mental State Examination User's Guide. Odessa, FL, USA: PAR Psychological Assessment Resources, Inc., 2000.
-
(2000)
MMSE - Mini-Mental State Examination User's Guide
-
-
Folstein, M.F.1
Folstein, S.E.2
McHugh, P.R.3
Fanjang, G.4
-
13
-
-
0033755037
-
Use of donepezil for the treatment of mild-moderate Alzheimer's disease: An audit of the assessment and treatment of patients in routine clinical practice
-
Cameron I, Curran S, Newton P, Petty D, Wards J. Use of donepezil for the treatment of mild-moderate Alzheimer's disease: an audit of the assessment and treatment of patients in routine clinical practice. Int J Geriatr Psychiatry 2000; 15: 887-91.
-
(2000)
Int. J. Geriatr. Psychiatry
, vol.15
, pp. 887-891
-
-
Cameron, I.1
Curran, S.2
Newton, P.3
Petty, D.4
Wards, J.5
|